Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma (KarMMa-7) KARMMA-7

What's the purpose of this trial?

This is a global, open-label, multi-arm, multi-cohort, multi-center, phase 1/2 study to determine the safety, tolerability, efficacy, PK of bb2121 in combination with other therapies in adult subjects with R/RMM.

This trial is currently open and accepting patients.

What will happen during the trial?

Additional Trial Information

Phase 1/2

Enrollment: 415 patients (estimated)

View More

Trial Locations

All Trial Locations

View all clinical trial locations sorted by state.


University of California San Francisco (Fresno Campus)

Fresno, CA

Not Yet Accepting


Mayo Clinic (Jacksonville)

Jacksonville, FL

Not Yet Accepting


Winship Cancer Institute of Emory University

Atlanta, GA

Not Yet Accepting

Northside Hospital

Atlanta, GA

Not Yet Accepting


Northwestern University Feinberg School of Medicine

Chicago, IL

Not Yet Accepting



Massachusetts General Hospital

Boston, MA

Not Yet Accepting

New Jersey

John Theurer Cancer Center Hackensack Meridian Health

Hackensack, NJ

Not Yet Accepting

New York

NewYork-Presbyterian/ Weill Cornell Medical Center

New York, NY

Not Yet Accepting

Mount Sinai Hospital Tisch Cancer Institute

New York, NY

Not Yet Accepting

North Carolina

Levine Cancer Institute Atrium Health

Charlotte, NC

Not Yet Accepting

Duke Cancer Center Duke University Medical Center

Durham, NC

Not Yet Accepting


Sidney Kimmel Cancer Center Thomas Jefferson University

Philadelphia, PA

Not Yet Accepting

University of Pennsylvania Presbyterian Medical Center

Philadelphia, PA

Not Yet Accepting


Sarah Cannon TriStar Centennial Medical Center

Nashville, TN

Open and Accepting


MD Anderson Cancer Center The University of Texas

Houston, TX

Not Yet Accepting
Interested in this trial?
  • Call us today 😀 keyboard_arrow_right

    We know how difficult and confusing this process can be. If you are interested in this clinical trial or have questions, you can call us at any time. You can also send us a direct message with questions.

    (888) 828-2206
  • If you are interested in keeping an eye on this trial, you can add it to your list of favorite trials. We'll send you alerts when this trial is updated.

  • Talk to your doctor keyboard_arrow_right

    You can print an overview of this trial to take in to your next appointment. Your doctor can help you understand if this trial may be right for you.

Still need help? Send us a message